Login Register
icon_bulk_orderBulk order Acrobiosystems for English
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > NOTCH2


Brief Information

Name:Neurogenic locus notch homolog protein 2
Target Synonym:N2ECD,NOTCH2,N2ICD,Notch 2,hN2,Neurogenic Locus Notch Homolog Protein 2,Notch (Drosophila) Homolog 2,Notch Homolog 2 (Drosophila),Notch Homolog 2,HJCYS,AGS2,Receptor, Notch2,Notch Receptor 2
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
NO2-H5255 Human Human NOTCH2 Protein, Fc Tag (MALS verified)

Part of Bioactivity data


Loaded Human NOTCH2, Fc Tag (Cat. No. NO2-H5255) on Protein A Biosensor, can bind Human DLL4, His Tag (Cat. No. DL4-H5227) with an affinity constant of 77.6 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Human NOTCH2, Fc Tag (Cat. No. ) MALS images

The purity of Human NOTCH2, Fc Tag(Cat. No. NO2-H5255) is more than 85% and the molecular weight of this protein is around 175-190 kDa verified by SEC-MALS.

Human NOTCH2, Fc TagHuman NOTCH2, Fc Tag (Cat. No. NO2-H5255) ELISA bioactivity

Immobilized Human DLL4, His Tag (Cat. No. DL4-H5227) at 5 μg/mL (100 μL/well) can bind Human NOTCH2, Fc Tag (Cat. No. NO2-H5255) with a linear range of 5-78 ng/mL (QC tested).

Synonym Name



Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus . Affects the implementation of differentiation, proliferation and apoptotic programs (By similarity). Involved in bone remodeling and homeostasis. In collaboration with RELA/p65 enhances NFATc1 promoter activity and positively regulates RANKL-induced osteoclast differentiation . Positively regulates self-renewal of liver cancer cells .

Clinical and Translational Updates

    Clinical Drug Information

    Name Research Code Research Phase Company Indications Clinical Trials
    Tarextumab OMP-59R5 Oncomed Pharmaceuticals Inc Details

    This web search service is supported by Google Inc.

    Call us
    Call us
    North America: +1 800-810-0816 (Toll Free)
    Asia & Pacific: +86 400-682-2521
    +1 888-377-6111
    1 Innovation Way, Newark, DE 19711, USA

    Leave a message